Showing results (221-230 of 435) with videos related to
Sort By:
Pageof 44
Cancer Discovery|April 12, 2022
Precision Combination Therapies Based on Recurrent Oncogenic CoalterationsXubin Li, Elisabeth K Dowling, Gonghong Yan, et al.International Journal of Radiation Oncology, Biology, Physics|January 17, 2009
Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: incidence, risk factors, and clinical courseMichael P Herman, Scott Kopetz, Priya R Bhosale, et al.Journal of the National Cancer Institute|December 27, 2025
Impact of KRAS codon-specific mutations on survival in metastatic CRC on trifluridine-tipiracil with/without bevacizumabGiulia Maddalena, Ymke van der Pol, Oscar E Villarreal, et al.Nature Communications|May 15, 2025
Long-Term Efficacy of Pembrolizumab and the Clinical Utility of ctDNA in Locally Advanced dMMR/MSI-H Solid TumorsMichael LaPelusa, Wei Qiao, Bryan Iorgulescu, et al.Oncotarget|November 4, 2015
5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traitsCorti Denise, Paolo Paoli, Maura Calvani, et al.NAR Genomics and Bioinformatics|June 30, 2025
Novel treatment-specific causal biomarkers for colorectal cancer by omics integrationAkram Yazdani, Azam Yazdani, Raul Mendez-Giraldez, et al.Nature Medicine|January 25, 2025
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trialScott Kopetz, Takayuki Yoshino, Eric Van Cutsem, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 13, 2007
Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survivalYun Shin Chun, Jean-Nicolas Vauthey, Dario Ribero, et al.Scientific Reports|February 22, 2020
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignanciesYudong Wang, Filip Janku, Sarina Piha-Paul, et al.BMJ Open|September 25, 2021
BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancerPashtoon Murtaza Kasi, Sarah Sawyer, Jessica Guilford, et al.Pageof 44